EN1L
VRTX icon

Engine No 1 LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Engine No 1 LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,739
Closed -$382K – 283
2021
Q4 		$382K Buy
1,739
+340
+24% +$66.1K 0.08% 161
2021
Q3 		$254K Buy
+1,399
New +$273K 0.07% 174

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Engine No 1 LLC's VRTX Position: Q1 2022 in Review

Engine No 1 LLC sold out of Vertex Pharmaceuticals (VRTX) in Q1 2022, closing a stake of 1,739 shares — an estimated $382K sold.

Engine No 1 LLC first reported a position in VRTX in Q3 2021 and held it in 2 quarters. The position peaked at $382K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

  • Engine No 1 LLC reported no remaining Vertex Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Engine No 1 LLC sold 1,739 Vertex Pharmaceuticals shares in Q1 2022, an estimated $382K.
  • Engine No 1 LLC first reported a position in Vertex Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Engine No 1 LLC's Vertex Pharmaceuticals position peaked at $382K in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on Engine No 1 LLC's 13F filing for Q1 2022, filed 13 May 2022.